The interlab study is a new feature of iGEM this year. As part of the measurement track, we participated in the interlab study as described on the Interlab Study page. The purpose of this study was to measure the fluorescence of three different devices, two of which we constructed in lab from biobrick parts. The third device was simply recovered from the 2014 parts kit. Below we detail our interlab study experience and discuss what are findings mean.
Devices Measured
Figure 1. Triplicate liquid cultures of each construct
1. The first device is [http://parts.igem.org/Part:BBa_I20260 BBa_I20260], which is a composite biobrick part that contains:
A promoter, [http://parts.igem.org/Part:BBa_J23101 BBa_J23101], a downstream gene ([http://parts.igem.org/Part:BBa_E0240 BBa_E0240]), and a backbone ([http://parts.igem.org/Part:pSB1C3 pSB1C3]).
The downstream gene is also a composite of a number of biobrick parts, including an RBS - [http://parts.igem.org/Part:BBa_B0032 B0032], a GFP coding sequence - [http://parts.igem.org/Part:BBa_E0040 E0040], and a transcriptional terminator - [http://parts.igem.org/Part:BBa_B0015 B0015].
2. The second device was cloned in lab, as described in the interlab study procedure.
The device is composed of [http://parts.igem.org/Part:BBa_J23101 BBa_J23101] and [http://parts.igem.org/Part:BBa_E0240 BBa_E0240], which are the same parts as in the first device.
However, the backbone of this device is different, [http://parts.igem.org/Part:pSB3K3 pSB3K3].
3. The third device was also cloned in lab, as described in the interlab study procedure.
The device is composed of [http://parts.igem.org/Part:BBa_J23115 BBa_J23115] and [http://parts.igem.org/Part:BBa_E0240 BBa_E0240], which is the same downstream gene as in devices 1 and 2. However, the promoter sequence of device 3 is different.
This device is in [http://parts.igem.org/Part:pSB1C3 pSB1C3], the same backbone as the first device.
Protocols
Sample Preparation
First, inoculate triplicate 10 mL cultures of LB with frozen stocks of the three devices (in TOP10 cells; I20260, J23101+E0240, J23115+E0240), a cell background control (TOP10 cells), and an LB only control in a 50 mL Erlenmeyer flask. Grow for 16-18 hours at 37°C, shaking at 300rpm.
The next morning, add 10µL of each overnight culture to 10 mL of LB with three replicates of each (15 total flasks) and grow 16-18 hours at 37°C, shaking at 300rpm. Triplicate cultures were continued.
After 16-18 hours, add 80 µL of each culture to the wells of a clear-bottomed black 96-well plate.
The fluorescence of each sample was measured using a 96-well plate as follows:
The 96-well plate was inserted into an Infinite 200 PRO Microplate Reader
Then, using the Tecan i-control the proper settings were selected and recorded.
The Settings were: Excitation at 480 (9 nm width) and Emission at 525 (20 nm width) with optimal gain.
Finally, the plate reader measured the fluorescence and the absorbance (OD600) for each well.
Sequencing Data
http://parts.igem.org/Promoters/Catalog/Anderson
After sequencing our constructs, we aligned them to the reference part sequences.
While constructs 1 and 2 were consistent with the references, we were surprised to see two point mutations in construct 3. This seemed highly unlikely to have occurred. As such, we consulted the parts registry and found that the sequence analysis of the spring 2014 plate shows two point mutations consistent with our sequence reads.
Figure 2. Relative fluorescence data for the three parts measured.
Data was collected using Infinite 200 PRO Microplate Reader and a 96 well black plate with 80 µl of culture per well. As shown in Figure 2, we used triplicate cultures and took averages of each set to represent the measured relative fluorescence of the part. Our representation of the data subtracts the fluorescence of the media background from the GFP signal, and then is divided by the OD600 of the cell culture with the OD600 of the media subtracted, or (GFP-LBbkgd)/(OD600-OD600LBbkgd).
Despite the genetic similarities in the devices—all three contained the same coding sequence, two devices had the same backbone and two devices had the same promoter sequence—there were stark differences in the amount of fluorescence produced by each of the devices.
While we expected the device with a strong promoter and the highest copy number plasmid to have the highest fluorescence, we did not observe this to be the case. Instead, we saw that the two constructs with the same promoter and coding region in both the medium copy number plasmid pSB3K3 and the high copy number plasmid pSB1C3 actually yielded the strongest fluorescence signal in the medium copy number plasmid. It is possible that the high copy number plasmid pSB1C3 had a negative effect on overall fluorescence—perhaps it became toxic or slowed cell growth. However, it is also possible that we may have swapped cultures or mislabeled an initial eppendorf or culture tube. If not, we consider that the medium copy plasmid pSB3K3, while lower copy number than pSB1C3, may be a better expression platform for this protein.
In comparing the constructs with the same coding sequence and plasmid backbone but different promoters, it should be noted that the sequence of the promoter J23115 used in our measurements differed by two bases from the reference sequence in the registry. While the sequence we used is consistent with the Spring 2014 Kit Distribution sequence analysis performed by the Biobricks Foundation, it is likely that the promoter we used may have a different activity than the reference sequence. We observed that the promoter J23101 showed a several-fold stronger signal than our mutated promoter J23115. While the [http://parts.igem.org/Promoters/Catalog/Anderson measured relative fluorescence data] of the reference sequences generally agrees with our data, the mutated J23115 shows slightly less activity compared to the reference.
"
